Lidocaine spray 10 min prior to intubation: effects on postoperative sore throat.
A sore throat is the most frequent adverse side effect of general anesthesia. The purpose of this study was to compare the different types and timing of lidocaine application based on the effectiveness of reducing postoperative sore throat (POST) after endotracheal intubation. In group A, 8% lidocaine was sprayed on laryngopharyngeal structures immediately before intubation, and the distal ends of the endotracheal tubes (ETTs) were lubricated with 2% lidocaine gel. In group B, 8% lidocaine was sprayed, and ETTs were lubricated with normal saline. In groups C and D, no lidocaine was sprayed, and the ETTs were lubricated with normal saline (C, control) or with 2% lidocaine gel (D). In group E, 8% lidocaine was sprayed 10 min prior to endotracheal intubation, and the ETTs were lubricated with normal saline. In 527 patients, 28.2% reported POST at 24 h following extubation. Statistically significant differences in the incidence of POST were found only between group E (16.0%) and each of the other groups (28.4-38.5%), except for group B (26.5%). In conclusion, 8% lidocaine spray significantly reduced the incidence of POST if it was sprayed on laryngopharyngeal structures 10 min prior to endotracheal intubation.
Honma
Kaneatsu
K
Division of Surgical Operation Center, Akiru Municipal Medical Center, 78-1 Hikida, Akiruno, Tokyo 197-0834, Japan. khonma@tc5.so-net.ne.jp
Kamachi
Masaaki
M
Akamatsu
Yoshihiko
Y
Yoshioka
Masami
M
Yamashita
Natsumi
N
D000280:Administration, Inhalation; D000368:Aged; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007442:Intubation, Intratracheal / Q000009:adverse effects; D008012:Lidocaine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D010612:Pharyngitis / Q000517:prevention & control*; D011183:Postoperative Complications / Q000517:prevention & control*; D012307:Risk Factors
D000779:Anesthetics, Local; D008012:Lidocaine
J Clin Anesth. 1997 Feb;9(1):42-7
9051545
Anaesthesia. 1992 Mar;47(3):213-6
1566989
Br J Pharmacol. 2007 May;151(1):153-60
17351650
Eur J Anaesthesiol. 2000 Jul;17(7):436-42
10964145
Anaesthesia. 1993 Apr;48(4):355-6
8494161
J Dent. 2009 Feb;37(2):93-7
19058888
J Clin Anesth. 1997 Aug;9(5):394-7
9257206
Eur J Anaesthesiol. 1988 Nov;5(6):391-9
3240760
Anaesthesia. 1999 May;54(5):444-53
10995141
Anesth Analg. 1997 Sep;85(3):573-7
9296411
Anaesthesia. 1987 Oct;42(10):1104-7
3688395
Br J Anaesth. 1994 Dec;73(6):786-7
7880666
Can Anaesth Soc J. 1980 Mar;27(2):156-8
7363144
J Clin Anesth. 2004 Feb;16(1):79-80; author reply 80
14984868
J Clin Anesth. 2002 Feb;14(1):15-8
11880016